Explore 3 Stock Ideas & Industry Insights Download Free Report

News

The 107-Year-Old Transformer Company Quietly Becoming an AI Infrastructure Bottleneck

For much of the past two years, investor attention around AI infrastructure has focused almost exclusively on semiconductors,Cloud Computinggiants and data-center operators. Companies making GPUs, cooling systems and networking hardware became the obvious beneficiaries of the generative AI arms race.

Nitish Kishor | 19 May 2026

OpenAI’s Deployment Company Is a Direct Threat to the Global IT Services Industry

The artificial intelligence arms race has so far been defined by semiconductor companies, cloud providers and software platforms. But OpenAI’s latest strategic move suggests the next battleground may emerge somewhere far larger and economically more consequential: the global IT services industry.

Nitish Kishor | 19 May 2026

MetaVia (NASDAQ: MTVA) — Analyst Backs GLP-1 Challenger With $20 Price Target

MetaVia (NASDAQ: MTVA) received a vote of confidence fromWall Streetthis week as an analyst at H.C. Wainwright maintained a Buy rating on the stock with a $20.00 price target. The endorsement centres on DA-1726, the company's lead asset and its bid to carve out …

Nitish Kishor | 19 May 2026

Onconetix, Inc. (NASDAQ: ONCO) — Reverse Split Sets Stage for Robotics Pivot

Onconetix, Inc. (NASDAQ: ONCO) has announced a significant corporate restructuring move that signals a dramatic strategic shift for the company. TheBoard of Directorshas approved a 1-for-10 reverse stock split of its common stock, set to take effect at market open on May 21, 2026. …

Nitish Kishor | 19 May 2026

Dogwood Therapeutics, Inc. (NASDAQ: DWTX) — Non-Opioid Pain Drug Advances Into 12-Week Extension

Dogwood Therapeutics, Inc. (Nasdaq: DWTX) announced the commencement of a 12-week open-label Phase 2b extension study for Halneuron, its first-in-class non-opioid analgesic targeting chemotherapy-induced neuropathic pain. The extension follows a positive pre-planned interim analysis from the ongoing 4-week double-blinded Phase 2b study — a …

Nitish Kishor | 19 May 2026

GeoVax Labs, Inc. (NASDAQ: GOVX) — Patent Confirmation Anchors MVA Platform Credibility

GeoVax Labs, Inc. (Nasdaq: GOVX) confirmed this week that it holds U.S. Patent No. 11,701,418, covering its Modified Vaccinia Ankara viral vector platform engineered to express Ebola virus glycoprotein and matrix protein. The patent protects a platform designed to generate noninfectious virus-like particles that …

Nitish Kishor | 19 May 2026
Support

Hi! How can we help you today?

Loading…